About Amin Benyounes, MD
Dr. Amin Benyounes is a thoracic oncologist board eligible in medical oncology and board certified in hematology and internal medicine. He joined Inova Health System in 2020 and has been practicing since 2016.
Prior to joining Inova, Dr. Benyounes worked as an Assistant Professor of Medicine at the University of Maryland School of Medicine in Baltimore, MD.
Benyounes A, Ma N, Kocoglu M, Patel A, Rapoport A, Binion K, Bosley R, Milliron T, Lederer E, Badros A. Racial disparities in multiple myeloma patients with durable stringent complete response. Clinical Lymphoma, Myeloma and Leukemia, Vol. 19,Issue 10, 2019, e287.
Benyounes A, Pathak A, Binder EL, Hausner PF. An attempt to better understand radiation recall events: A literature review. J Clin Oncol 36, 2018 (suppl; abstr e22109).
Benyounes A, Ackler J, DeVincenzo S, Tester W, Leighton Jr J.C. Adherence to oral immunomodulatory therapy at a community cancer center. Clinical Lymphoma, Myeloma and Leukemia, 2015 Vol. 15, e192.
Benyounes A, Candelario N, Braitman L, Leighton Jr J.C, Tester W, Varadi G. Qbleed Score in an African American Cohort. Blood 2015 126:1092.
Vargas F, Benyounes A, Varadi G. Statin use and its effect on skeletal related events in patients with multiple myeloma. Blood 2014 124:5774.
Benyounes A, Tester W, Leighton Jr J.C. Proteinuria monitoring in patient receiving bevacizumab at a community cancer center. J Clin Oncol 32, 2014 (suppl 30; abstr 13).
Medical EducationUniversity of Freiburg School of Medicine 2012
Training Specialty: Internal Medicine
07/01/2013 - 06/30/2016
Training Specialty: Hematology / Oncology
07/1/2016 - 06/30/2019